Read + Share
Leiva O, Elgendy IY. In adults with MI and LVEF >40% after invasive care, beta-blocker therapy did not
reduce a composite adverse outcome at a median 3.7 y. Ann Intern Med 2025;178:JC134.
PMID: 41325618
|
 |
|
Leiva O, Elgendy IY. In adults with MI and LVEF >40% after invasive care, beta-blocker therapy did not
reduce a composite adverse outcome at a median 3.7 y. Ann Intern Med 2025;178:JC134.
PMID: 41325618
|
|
|
|